Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies

Tsuyoshi Ueno, Junichi Sou, Takao Hiraki, Hiroaki Asano, Koichi Ichimura, Kentaro Shibamoto, Hideo Gobara, Susumu Kanazawa, Shinichi Toyooka, Shinichiro Miyoshi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Activating mutations of the epidermal growth factor receptor (EGFR) gene are characteristic of non-small cell lung cancer (NSCLC). EGFR mutations were previously detected in histologically normal lung tissue around NSCLC tumors. Computed tomography-guided lung needle biopsy (CTNB) is an accurate and useful technique for the diagnosis of lung tumors. However, pathologically non-malignant cases occasionally become apparent following lung tumor resection. In this study, we determined the EGFR mutational status of lung tumors diagnosed as non-malignant in CTNB specimens, but diagnosed as NSCLC following surgical resection. Between 2000 and 2008, 1,109 CTNBs were performed at Okayama University Hospital. Among them, 15 cases were initially diagnosed as non-malignant by CTNB, but diagnosed as NSCLC following surgical resection as a result of a high likelihood of malignancy by clinical findings. Twelve paired DNAs of CTNB and corresponding resected specimens were available to examine the EGFR mutational status using a mutant-enriched PCR assay. EGFR mutations were detected in one out of 12 CTNB specimens and three of the corresponding resected tumors. This case harbored the same EGFR mutation in the CTNB specimen and resected tumor, but not in the distant corresponding non-malignant lung tissue. Our results indicated that the detection of EGFR mutations may therefore aid the diagnosis of NSCLC in pathologically non-malignant CTNB specimens.

Original languageEnglish
Pages (from-to)401-404
Number of pages4
JournalOncology Letters
Volume3
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Needle Biopsy
Epidermal Growth Factor Receptor
Tomography
Lung
Mutation
Non-Small Cell Lung Carcinoma
Neoplasms
erbB-1 Genes

Keywords

  • Computed tomography-guided lung needle biopsy
  • Epidermal growth factor receptor
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies. / Ueno, Tsuyoshi; Sou, Junichi; Hiraki, Takao; Asano, Hiroaki; Ichimura, Koichi; Shibamoto, Kentaro; Gobara, Hideo; Kanazawa, Susumu; Toyooka, Shinichi; Miyoshi, Shinichiro.

In: Oncology Letters, Vol. 3, No. 2, 02.2012, p. 401-404.

Research output: Contribution to journalArticle

@article{b3dcab304a254eec87649185e85a87c5,
title = "Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies",
abstract = "Activating mutations of the epidermal growth factor receptor (EGFR) gene are characteristic of non-small cell lung cancer (NSCLC). EGFR mutations were previously detected in histologically normal lung tissue around NSCLC tumors. Computed tomography-guided lung needle biopsy (CTNB) is an accurate and useful technique for the diagnosis of lung tumors. However, pathologically non-malignant cases occasionally become apparent following lung tumor resection. In this study, we determined the EGFR mutational status of lung tumors diagnosed as non-malignant in CTNB specimens, but diagnosed as NSCLC following surgical resection. Between 2000 and 2008, 1,109 CTNBs were performed at Okayama University Hospital. Among them, 15 cases were initially diagnosed as non-malignant by CTNB, but diagnosed as NSCLC following surgical resection as a result of a high likelihood of malignancy by clinical findings. Twelve paired DNAs of CTNB and corresponding resected specimens were available to examine the EGFR mutational status using a mutant-enriched PCR assay. EGFR mutations were detected in one out of 12 CTNB specimens and three of the corresponding resected tumors. This case harbored the same EGFR mutation in the CTNB specimen and resected tumor, but not in the distant corresponding non-malignant lung tissue. Our results indicated that the detection of EGFR mutations may therefore aid the diagnosis of NSCLC in pathologically non-malignant CTNB specimens.",
keywords = "Computed tomography-guided lung needle biopsy, Epidermal growth factor receptor, Non-small cell lung cancer",
author = "Tsuyoshi Ueno and Junichi Sou and Takao Hiraki and Hiroaki Asano and Koichi Ichimura and Kentaro Shibamoto and Hideo Gobara and Susumu Kanazawa and Shinichi Toyooka and Shinichiro Miyoshi",
year = "2012",
month = "2",
doi = "10.3892/ol.2011.471",
language = "English",
volume = "3",
pages = "401--404",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies

AU - Ueno, Tsuyoshi

AU - Sou, Junichi

AU - Hiraki, Takao

AU - Asano, Hiroaki

AU - Ichimura, Koichi

AU - Shibamoto, Kentaro

AU - Gobara, Hideo

AU - Kanazawa, Susumu

AU - Toyooka, Shinichi

AU - Miyoshi, Shinichiro

PY - 2012/2

Y1 - 2012/2

N2 - Activating mutations of the epidermal growth factor receptor (EGFR) gene are characteristic of non-small cell lung cancer (NSCLC). EGFR mutations were previously detected in histologically normal lung tissue around NSCLC tumors. Computed tomography-guided lung needle biopsy (CTNB) is an accurate and useful technique for the diagnosis of lung tumors. However, pathologically non-malignant cases occasionally become apparent following lung tumor resection. In this study, we determined the EGFR mutational status of lung tumors diagnosed as non-malignant in CTNB specimens, but diagnosed as NSCLC following surgical resection. Between 2000 and 2008, 1,109 CTNBs were performed at Okayama University Hospital. Among them, 15 cases were initially diagnosed as non-malignant by CTNB, but diagnosed as NSCLC following surgical resection as a result of a high likelihood of malignancy by clinical findings. Twelve paired DNAs of CTNB and corresponding resected specimens were available to examine the EGFR mutational status using a mutant-enriched PCR assay. EGFR mutations were detected in one out of 12 CTNB specimens and three of the corresponding resected tumors. This case harbored the same EGFR mutation in the CTNB specimen and resected tumor, but not in the distant corresponding non-malignant lung tissue. Our results indicated that the detection of EGFR mutations may therefore aid the diagnosis of NSCLC in pathologically non-malignant CTNB specimens.

AB - Activating mutations of the epidermal growth factor receptor (EGFR) gene are characteristic of non-small cell lung cancer (NSCLC). EGFR mutations were previously detected in histologically normal lung tissue around NSCLC tumors. Computed tomography-guided lung needle biopsy (CTNB) is an accurate and useful technique for the diagnosis of lung tumors. However, pathologically non-malignant cases occasionally become apparent following lung tumor resection. In this study, we determined the EGFR mutational status of lung tumors diagnosed as non-malignant in CTNB specimens, but diagnosed as NSCLC following surgical resection. Between 2000 and 2008, 1,109 CTNBs were performed at Okayama University Hospital. Among them, 15 cases were initially diagnosed as non-malignant by CTNB, but diagnosed as NSCLC following surgical resection as a result of a high likelihood of malignancy by clinical findings. Twelve paired DNAs of CTNB and corresponding resected specimens were available to examine the EGFR mutational status using a mutant-enriched PCR assay. EGFR mutations were detected in one out of 12 CTNB specimens and three of the corresponding resected tumors. This case harbored the same EGFR mutation in the CTNB specimen and resected tumor, but not in the distant corresponding non-malignant lung tissue. Our results indicated that the detection of EGFR mutations may therefore aid the diagnosis of NSCLC in pathologically non-malignant CTNB specimens.

KW - Computed tomography-guided lung needle biopsy

KW - Epidermal growth factor receptor

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=84855225824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855225824&partnerID=8YFLogxK

U2 - 10.3892/ol.2011.471

DO - 10.3892/ol.2011.471

M3 - Article

VL - 3

SP - 401

EP - 404

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 2

ER -